The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index.
Site-selective modification strategies in antibody–drug conjugates
Open accessAbstract
Antibody–drug conjugates (ADCs) harness the highly specific targeting capabilities of an antibody to deliver a cytotoxic payload to specific cell types. This review summarises the advances made in the construction of homogenous ADCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–291 of 291
Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug Conjugates
DeVay, R. M., Delaria, K., Zhu, G., Holz, C., Foletti, D. L., Sutton, J. E., Bolton, G. L., Dushin, R. G., Bee, C., Pons, J., et al. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00013 · Cited by 67
Antibody internalization studied using a novel IgG binding toxin fusion
Mazor, Y., Barnea, I., Keydar, I., & Benhar, I. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.01.008 · Cited by 66
Homogeneous antibody-drug conjugates via site-selective disulfide bridging
Forte, N., Chudasama, V., & Baker, J. R. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.09.004 · Cited by 66
Site-Specific Conjugation of Native Antibodies Using Engineered Microbial Transglutaminases
Dickgießer, S., Rieker, M., Müller-Pompalla, D., Schröter, C. J., Tonillo, J., Warszawski, S., Raab-Westphal, S., Kühn, S. F., Knehans, T., Könning, D., et al. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00061 · Cited by 65
Shinmi, D., Taguchi, E., Iwano, J., et al. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00133 · Cited by 63
Yokoyama, K.-I., Utsumi, H., Nakamura, T., Ogaya, D., Shimba, N., Suzuki, E., & Taguchi, S. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2656-6 · Cited by 62
Lee, M. T. W., Maruani, A., Richards, D. A., Baker, J. R., Caddick, S., & Chudasama, V. (2016) · Chemical Science · doi:10.1039/c6sc03655d · Cited by 62
Development and evaluation of β-galactosidase-sensitive antibody-drug conjugates
Kolodych, S., Michel, C., Delacroix, S., Koniev, O., Ehkirch, A., Eberová, J., Cianférani, S., Renoux, B., Krężel, W., Poinot, P., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.08.008 · Cited by 62
Spycher, P. R., Amann, C. A., Wehrmüller, J. E., Hurwitz, D. R., Kreis, O., Messmer, D., Ritler, A., Küchler, A., Blanc, A., Béhé, M. P., et al. (2017) · ChemBioChem · doi:10.1002/cbic.201700188 · Cited by 62
Sadowsky, J., Pillow, T. H., Chen, J., Fan, F., He, C., Wang, Y., Yan, G., Yao, H., Xu, Z., Martin, S. A., et al. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00258 · Cited by 61
Recent progress in transglutaminase-mediated assembly of antibody-drug conjugates
Schneider, H., Deweid, L., Avrutina, O., & Kolmar, H. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.113615 · Cited by 61
Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells
Brandish, P. E., Palmieri, A., Antonenko, S. V., Beaumont, M., Benso, L., Cancilla, M. T., Cheng, M. M., Fayadat‐Dilman, L., Feng, G., Figueroa, I., et al. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00312 · Cited by 60
Liberatore, F. A., Comeau, R. D., McKearin, J. M., et al. (1990) · Bioconjugate Chemistry · doi:10.1021/bc00001a005 · Cited by 59
Single-site labeling of lysine in proteins through a metal-free multicomponent approach
Chilamari, M., Kalra, N., Shukla, S., & Rai, V. (2018) · Chemical Communications · doi:10.1039/c8cc03311k · Cited by 59
Hanna, K. S. (2019) · Drugs · doi:10.1007/s40265-019-01241-7 · Cited by 59
Nunes, J. P. M., Vassileva, V., Robinson, E., Morais, M., Smith, M. E. B., Pedley, R. B., Caddick, S., Baker, J. R., & Chudasama, V. (2017) · RSC Advances · doi:10.1039/c7ra04606e · Cited by 57
Generation and validation of structurally defined antibody–siRNA conjugates
Nanna, A. R., Kel’in, A. V., Theile, C. S., Pierson, J. M., Voo, Z. X., Garg, A., Nair, J. K., Maier, M. A., Fitzgerald, K. J., & Rader, C. M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa286 · Cited by 56
Stan, A. C., Radu, D. L., Casares, S. A., Bona, C. A., & Brumeanu, T. (1999) · PubMed · Cited by 55
Puthenveetil, S., Musto, S., Loganzo, F., et al. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00054 · Cited by 55
Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues
Li, X., Patterson, J. T., Sarkar, M., Pedzisa, L., Kodadek, T. J., Roush, W. R., & Rader, C. M. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00244 · Cited by 55
Sussman, D. R., Westendorf, L., Meyer, D. W., Leiske, C. I., Anderson, M. E., Okeley, N. M., Alley, S. C., Lyon, R. P., Sanderson, R., Carter, P. J., et al. (2018) · Protein Engineering Design and Selection · doi:10.1093/protein/gzx067 · Cited by 55
Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001
Abrahams, C. L., Li, X., Embry, M. G., Yu, A., Krimm, S., Krueger, S. A., Greenland, N., Wen, K. W., Jones, C., DeAlmeida, V. I., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26491 · Cited by 55
Bryden, F., Martin, C., Letast, S., et al. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob02780j · Cited by 54
On enzymatic remodeling of IgG glycosylation; unique tools with broad applications
Sjögren, J., Lood, R., & Naegeli, A. (2019) · Glycobiology · doi:10.1093/glycob/cwz085 · Cited by 54
Forte, N., Livanos, M., Miranda, E., Morais, M., Yang, X., Rajkumar, V. S., Chester, K. A., Chudasama, V., & Baker, J. R. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00795 · Cited by 52
Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody–Drug Conjugates
Neumann, C. S., Olivas, K. C., Anderson, M. E., Cochran, J. H., Jin, S., Li, F., Loftus, L. V., Meyer, D. W., Neale, J. R., Nix, J. C., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0643 · Cited by 51
Microbial transglutaminase: An overview of recent applications in food and packaging
Mostafa, H. S. (2020) · Biocatalysis and Biotransformation · doi:10.1080/10242422.2020.1720660 · Cited by 50
Site-Specific Antibody Conjugation Strategy to Functionalize Virus-Based Nanoparticles
Park, J., Chariou, P. L., & Steinmetz, N. F. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00118 · Cited by 50
Garbe, J., & Collin, M. (2012) · Journal of Innate Immunity · doi:10.1159/000334775 · Cited by 49
Grünewald, J., Klock, H. E., Cellitti, S. E., Bursulaya, B. D., McMullan, D., Jones, D. H., Chiu, H., Wang, X., Patterson, P., Zhou, H., et al. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00558 · Cited by 49
York, D., Baker, J., Holder, P. G., et al. (2016) · BMC Biotechnology · doi:10.1186/s12896-016-0254-0 · Cited by 49
Dovgan, I., Erb, S., Hessmann, S., Ursuegui, S., Michel, C., Muller, C. D., Chaubet, G., Cianférani, S., & Wagner, A. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob02844j · Cited by 49
The “Utility” of Highly Toxic Marine-Sourced Compounds
Newman, D. J. (2019) · Marine Drugs · doi:10.3390/md17060324 · Cited by 49
Bahou, C., Love, E. A., Leonard, S., Spears, R. J., Maruani, A., Armour, K. L., Baker, J. R., & Chudasama, V. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00174 · Cited by 48
Harper, J. W., Lloyd, C., Dimasi, N., Toader, D., Marwood, R., Lewis, L., Bannister, D., Jovanovic, J., Fleming, R. L., D’Hooge, F., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0825 · Cited by 47
Satomaa, T., Pynnönen, H., Vilkman, A., Kotiranta, T., Pitkänen, V., Heiskanen, A., Herpers, B., Price, L., Helin, J., & Saarinen, J. (2018) · Antibodies · doi:10.3390/antib7020015 · Cited by 47
Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugates
Pabst, M., McDowell, W., Manin, A., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.027 · Cited by 46
Vollmar, B. S., Wei, B. Q., Ohri, R. V., Zhou, J., He, J., Yu, S., Leipold, D. D., Cosino, E., Yee, S. F., Fourie-O’Donohue, A., et al. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00365 · Cited by 46
Dovgan, I., Ursuegui, S., Erb, S., Michel, C., Kolodych, S., Cianférani, S., & Wagner, A. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00141 · Cited by 45
Zheng, Y., Addy, P., Mukherjee, R., & Chatterjee, A. (2017) · Chemical Science · doi:10.1039/c7sc02560b · Cited by 45
Manabe, S., Yamaguchi, Y., Matsumoto, K., Fuchigami, H., Kawase, T., Hirose, K., Mitani, A., Sumiyoshi, W., Kinoshita, T., Abe, J., et al. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00132 · Cited by 45
Computationally designed antibody–drug conjugates self-assembled via affinity ligands
Gupta, N., Ansari, A., Dhoke, G. V., Chilamari, M., Sivaccumar, J. P., Kumari, S., Chatterjee, S., Goyal, R., Dutta, P. K., Samarla, M., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0470-8 · Cited by 45
DOTAGA-Trastuzumab. A New Antibody Conjugate Targeting HER2/Neu Antigen for Diagnostic Purposes
Moreau, M., Raguin, O., Vrigneaud, J., Collin, B., Bernhard, C., Tizon, X., Boschetti, F., Duchamp, O., Brunotte, F., & Denat, F. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200680x · Cited by 44
Roy, G., Reier, J., Garcia, A., Martin, T., Rice, M., Wang, J., Prophet, M., Christie, R., Dall'acqua, W., Ahuja, S., et al. (2019) · mAbs · doi:10.1080/19420862.2019.1684749 · Cited by 44
Antibody conjugation via one and two C-terminal selenocysteines
Li, X., Yang, J., & Rader, C. M. (2013) · Methods · doi:10.1016/j.ymeth.2013.05.023 · Cited by 43
Dual Site-Specific Antibody Conjugates for Sequential and Orthogonal Cargo Release
Thornlow, D. N., Cox, E. C., Walker, J. A., Sorkin, M. R., Plesset, J. B., DeLisa, M. P., & Alabi, C. A. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00244 · Cited by 43
Innovations for Next-Generation Antibody-Drug Conjugates
(2018) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-78154-9 · Cited by 42
Chih, H., Gikanga, B., Yang, Y. T., & Zhang, B. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22485 · Cited by 40
Development of a facile antibody–drug conjugate platform for increased stability and homogeneity
Gupta, N., Kancharla, J., Kaushik, S., Ansari, A., Hossain, S., Goyal, R., Pandey, M., Sivaccumar, J. P., Hussain, S., Sarkar, A., et al. (2016) · Chemical Science · doi:10.1039/c6sc05149a · Cited by 40
Walker, J. A., Bohn, J. J., Ledesma, F., Sorkin, M. R., Kabaria, S. R., Thornlow, D. N., & Alabi, C. A. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00522 · Cited by 40
Simultaneous Site-Specific Dual Protein Labeling Using Protein Prenyltransferases
Zhang, Y., Blanden, M. J., Sudheer, C., Gangopadhyay, S. A., Rashidian, M., Hougland, J. L., & Distefano, M. D. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00553 · Cited by 39
Yin, G., Stephenson, H. T., Yang, J., Li, X., Armstrong, S. M., Heibeck, T. H., Tran, C., Masikat, M. R., Zhou, S., Stafford, R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03192-z · Cited by 39
Generation of Potent Anti-HER1/2 Immunotoxins by Protein Ligation Using Split Inteins
Pirzer, T., Becher, K.-S., Rieker, M., Meckel, T., Mootz, H. D., & Kolmar, H. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00222 · Cited by 39
Enzymatic activity and thermoresistance of improved microbial transglutaminase variants
Böhme, B., Moritz, B., Wendler, J., Hertel, T. C., Ihling, C. H., Brandt, W., & Pietzsch, M. (2019) · Amino Acids · doi:10.1007/s00726-019-02764-9 · Cited by 38
Hwang, D., Tsuji, K., Park, H., Burke, T. R., & Rader, C. M. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00609 · Cited by 38
Peptide-Directed Photo-Cross-Linking for Site-Specific Conjugation of IgG
Park, J., Lee, Y., Ko, B. J., & Yoo, T. H. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00515 · Cited by 37
Matsuda, Y., Robles, V., Malinao, M.-C., Song, J., & Mendelsohn, B. A. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02192 · Cited by 37
Matsuda, Y., Clancy, C. M., Tawfiq, Z., Robles, V., & Mendelsohn, B. A. (2019) · ACS Omega · doi:10.1021/acsomega.9b02419 · Cited by 36
Shivatare, S. S., Huang, L., Zeng, Y., Liao, J.-Y., You, T.-H., Wang, S., Cheng, T., Chiu, C.-W., Chao, P., Chen, L.-T., et al. (2018) · Chemical Communications · doi:10.1039/c8cc03384f · Cited by 36
Amant, A. H. S., Huang, F., Lin, J., Rickert, K. W., Oganesyan, V., Lemen, D., Mao, S., Harper, J. W., Marelli, M., Wu, H., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201903494 · Cited by 35
Amant, A. H. S., Huang, F., Lin, J., Lemen, D., Chakiath, C., Mao, S., Fazenbaker, C. A., Zhong, H., Harper, J. W., Xu, W., et al. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00436 · Cited by 35
Sadiki, A., Kercher, E. M., Lu, H., Lang, R. T., Spring, B. Q., & Zhou, Z. S. (2020) · Photochemistry and Photobiology · doi:10.1111/php.13231 · Cited by 35
Thompson, P., Ezeadi, E., Hutchinson, I., Fleming, R. L., Bezabeh, B. Z., Lin, J., Mao, S.-L., Chen, C., Masterson, L. A., Zhong, H., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00278 · Cited by 34
Snyder, J., Malinao, M.-C., Dugal‐Tessier, J., Atkinson, J. E., Anand, B. S., Okada, A., & Mendelsohn, B. A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00225 · Cited by 34
Bryden, F., Maruani, A., Rodrigues, J. M. M., Cheng, M. H. Y., Savoie, H., Beeby, A., Chudasama, V., & Boyle, R. W. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00678 · Cited by 32
Synthesis of site-specific antibody-drug conjugates by ADP-ribosyl cyclases
Dai, Z., Zhang, X., Nasertorabi, F., Cheng, Q., Li, J., Katz, B. B., Smbatyan, G., Pei, H., Louie, S. G., Lenz, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba6752 · Cited by 32
Schneider, H., Deweid, L., Pirzer, T., Yanakieva, D., Englert, S., Becker, B., Avrutina, O., & Kolmar, H. (2019) · ChemistryOpen · doi:10.1002/open.201900066 · Cited by 31
General dual functionalisation of biomacromolecules via a cysteine bridging strategy
Walsh, S. J., Iegre, J., Seki, H., Bargh, J. D., Sore, H. F., Parker, J. S., Carroll, J. S., & Spring, D. R. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob00907e · Cited by 31
Self-citationWong, O. K., Tran, T.-T., Ho, W.-H., Casas, M. G., Au, M., Bateman, M. E., Lindquist, K. C., Rajpal, A., Shelton, D. L., Strop, P., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26002 · Cited by 30
Site-specific and hydrophilic ADCs through disulfide-bridged linker and branched PEG
Shao, S., Tsai, M., Lu, J., Yu, T., Jin, J., Xiao, D., Jiang, H., Han, M., Wang, M., & Wang, J. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.03.005 · Cited by 29
Site Selective Antibody-Oligonucleotide Conjugation via Microbial Transglutaminase
Huggins, I. J., Medina, C. A., Springer, A. D., van den Berg, A., Jadhav, S. G., Cui, X.-S., & Dowdy, S. F. (2019) · Molecules · doi:10.3390/molecules24183287 · Cited by 29
Mazor, Y., Noy, R., Wels, W. S., & Benhar, I. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.07.009 · Cited by 28
Hydrolytically Stable Site-Specific Conjugation at the N-Terminus of an Engineered Antibody
Thompson, P., Bezabeh, B. Z., Fleming, R. L., Pruitt, M., Mao, S., Strout, P., Chen, C., Cho, S., Zhong, H., Wu, H., et al. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00355 · Cited by 28
Matsuda, Y., Yamada, K., Okuzumi, T., & Mendelsohn, B. A. (2019) · Organic Process Research & Development · doi:10.1021/acs.oprd.9b00316 · Cited by 28
Drake, P. M., Carlson, A., McFarland, J. M., Bañas, S., Barfield, R. M., Zmolek, W., Kim, Y. C., Huang, B. C. B., Kudirka, R. A., & Rabuka, D. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0776 · Cited by 27
Herbener, P., Schönfeld, K., König, M. F., Germer, M., Przyborski, J. M., Bernöster, K., & Schüttrumpf, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195823 · Cited by 26
Iwamoto, M., Sekiguchi, Y., Nakamura, K., Kawaguchi, Y., Honda, T., & Hasegawa, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193534 · Cited by 25
Shi, B., Wu, M., Li, Z., Xie, Z., Wei, X., Fan, J., Xu, Y., Ding, D., Akash, M. S. H., Chen, S., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2066 · Cited by 25
Vance, N. R., Zacharias, N. T., Ultsch, M. H., Li, G., Fourie, A., Liu, P. X., Lafrance‐Vanasse, J., Ernst, J. A., Sandoval, W. N., Kozak, K. R., et al. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00809 · Cited by 24
Dual Site-Specific Labeling of an Antibody Fragment through Sortase A and π-Clamp Conjugation
Lee, M. D., Tong, W. Y., Nebl, T., Pearce, L. A., Pham, T. M., Hagh, A. G., Puttick, S. G., Rose, S., Adams, T. E., & Williams, C. C. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00639 · Cited by 23
Analytical techniques for the characterization of Antibody Drug Conjugates: Challenges and prospects
Neupane, R., & Bergquist, J. (2017) · European Journal of Mass Spectrometry · doi:10.1177/1469066717733919 · Cited by 21
Ratnayake, A. S., Chang, L.-P., Tumey, L. N., Loganzo, F., Chemler, J. A., Wagenaar, M., Musto, S., Li, F., Janso, J. E., Ballard, T. E., et al. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00843 · Cited by 21
Manabe, S., Yamaguchi, Y., Abe, J., Matsumoto, K., & Ito, Y. (2018) · Royal Society Open Science · doi:10.1098/rsos.171521 · Cited by 18
Mortensen, M. R., Skovsgaard, M. B., Okholm, A. H., Scavenius, C., Dupont, D. M., Rosen, C. B., Enghild, J. J., Kjems, J., & Gothelf, K. V. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00424 · Cited by 17
Expanding the Scope of Antibody Rebridging with New Pyridazinedione–TCO Constructs
Marquard, A. N., Carlson, J., & Weissleder, R. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00155 · Cited by 15
Zammarchi, F., Corbett, S., Adams, L. R., Mellinas‐Gomez, M., Tyrer, P. C., Dissanayake, S., Sims, S., Havenith, K., Chivers, S., Willimas, D. G., et al. (2016) · Blood · doi:10.1182/blood.v128.22.4176.4176 · Cited by 13
Barfield, R. M., Kim, Y. C., Chuprakov, S., Zhang, F., Bauzon, M., Ogunkoya, A. O., Yeo, D. Y., Hickle, C. L., Pegram, M. D., Rabuka, D., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0190 · Cited by 13
Targeting EGFR‐positive cancer cells with cetuximab–ZZ‐PE38: Results of in vitro and in vivo studies
Barnea, I., Ben-Yosef, R., Karaush, V., Benhar, I., & Vexler, A. M. (2012) · Head & Neck · doi:10.1002/hed.23093 · Cited by 12
Huang, L., Veneziale, B., Frigerio, M., Badescu, G. O., Li, X.-M., Zhao, Q., Bahn, J. D., Souratha, J., Osgood, R. J., Zhao, C., et al. (2016) · Cancer Research · doi:10.1158/1538-7445.am2016-1217 · Cited by 8
Harris, L., Tavares, D., Rui, L., et al. (2015) · Cancer Research · doi:10.1158/1538-7445.am2015-647 · Cited by 6
Rostovtsev, V. V., Green, L. G., Fokin, V. V., & Sharpless, K. B. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020715)41:14<2596::aid-anie2596>3.0.co;2-4
Cited by
Antibody drug conjugate: the “biological missile” for targeted cancer therapy
Fu, Z., Li, S., Han, S., Shi, C., & Zhang, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00947-7 · Cited by 1,643
Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability
Nguyen, T. D., Bordeau, B. M., & Balthasar, J. P. (2023) · Cancers · doi:10.3390/cancers15030713 · Cited by 441
An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy
Tong, J. T. W., Harris, P. W. R., Brimble, M. A., & Kavianinia, I. (2021) · Molecules · doi:10.3390/molecules26195847 · Cited by 287
Designing antibodies as therapeutics
Carter, P. J., & Rajpal, A. (2022) · Cell · doi:10.1016/j.cell.2022.05.029 · Cited by 267
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
Colombo, R., Tarantino, P., Rich, J. R., LoRusso, P. M., & de Vries, E. G. E. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0708 · Cited by 254
Metadata
- Authors
- Walsh, S. J., Bargh, J. D., Dannheim, F. M., Hanby, A. R., Seki, H., Counsell, A. J., Ou, X., Fowler, E., Ashman, N., Takada, Y., Isidro-Llobet, A., Parker, J. S., Carroll, J. S., & Spring, D. R.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 50
- Issue
- 2
- Pages
- 1305-1353
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W3111378088
- Cited by
- 461
- References
- 291
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.